<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mpath ids='MPATH_177'>Angiogenesis</z:mpath>, which plays a critical role during <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> development, is tightly regulated by the Sonic Hedgehog (SHH) pathway, which has been known to malfunction in many types of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Therefore, inhibition of <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> via modulation of the SHH signaling pathway has become very attractive for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> chemotherapy </plain></SENT>
<SENT sid="2" pm="."><plain>Scutellaria barbata D </plain></SENT>
<SENT sid="3" pm="."><plain>Don (SB) has long been used in China to treat various <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> including <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="4" pm="."><plain>Our published data suggested that the <z:chebi fb="37" ids="16236,44730">ethanol</z:chebi> extract of SB (EESB) is able to induce <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells and inhibit <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> in a chick embryo chorioallantoic membrane model </plain></SENT>
<SENT sid="5" pm="."><plain>To further elucidate the precise mechanisms of its anti-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> activity, in the present study we used a <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> mouse <z:e sem="disease" ids="C1520166" disease_type="Experimental Model of Disease" abbrv="">xenograft model</z:e> to evaluate the effect of EESB on <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> and <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> in vivo </plain></SENT>
<SENT sid="6" pm="."><plain>Our current data indicated that EESB reduces <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> size without affecting on the body <z:mp ids='MP_0005456'>weight gain</z:mp> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> mice </plain></SENT>
<SENT sid="7" pm="."><plain>In addition, EESB treatment suppresses the expression of key mediators of the SHH pathway in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissues, which in turn resulted in the inhibition of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>Furthermore, EESB treatment inhibits the expression of vascular endothelial growth factor A (VEGF-A), an important target gene of SHH signaling and functioning as one of the strongest stimulators of <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> </plain></SENT>
<SENT sid="9" pm="."><plain>Our findings suggest that inhibition of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> via suppression of the SHH pathway might be one of the mechanisms by which Scutellaria barbata D </plain></SENT>
<SENT sid="10" pm="."><plain>Don can be effective in the treatment of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
</text></document>